Trial Profile
A Post-Marketing Observational Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary) ; Antiandrogens; Antineoplastics
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Abbott Laboratories
- 10 Mar 2010 New trial record